Patents Assigned to Fujian Haixi Pharmaceuticals, Inc.
  • Compound for increasing kinase active and application thereof
    Patent number: 9409900
    Abstract: The compound of Formula (I), pharmaceutically acceptable salts thereof, solvates thereof, chelates thereof, non-covalent complexes thereof or produgs of compounds mentioned above or the mixture of any form above mentioned are provided. The use of the compounds in manufacturing a medicament for the treatment and/or prevention of diabetes, obesity and related disorders.
    Type: Grant
    Filed: November 9, 2011
    Date of Patent: August 9, 2016
    Assignees: FUJIAN HAIXI PHARMACEUTICALS, INC., BETTA PHARMACUETICALS CO., LTD.
    Inventors: Xinshan Kang, Wei Long, Cunbo Ma, Yanping Wang, Xiaoyan Shen, Yunyan Hu, Fenlai Tan, Yinxiang Wang
  • COMPOUND FOR INCREASING KINASE ACTIVE AND APPLICATION THEREOF
    Publication number: 20130225587
    Abstract: The compound of Formula (I), pharmaceutically acceptable salts thereof, solvates thereof, chelates thereof, non-covalent complexes thereof or produgs of compounds mentioned above or the mixture of any form above mentioned are provided. The use of the compounds in manufacturing a medicament for the treatment and/or prevention of diabetes, obesity and related disorders.
    Type: Application
    Filed: November 9, 2011
    Publication date: August 29, 2013
    Applicants: Zhejiang Beta Pharma Incorporation, Fujian Haixi Pharmaceuticals, Inc.
    Inventors: Xinshan Kang, Wei Long, Cunbo Ma, Yanping Wang, Xiaoyan Shen, Yunyan Hu, Fenlai Tan, Yinxiang Wang